Towards Evidence-based Management

  • James G. Thorton
  • Janet Hornbuckle


Although evidence-based medicine (EBM) describes a type of practice with which no-one can seriously disagree [1], it has also become a buzzword that irritates some doctors who see it eroding their clinical freedom. I hope to describe some of the key features of EBM as applied to fetal growth restriction and to demonstrate that the latter view is mistaken. The problem in clinical practice is mainly to do with information, and EBM is mainly concerned with dealing with information in a sensible way [2]. Sackett [1] defined EBM as converting information needs into answerable questions, tracking down the best evidence to answer them, critically appraising the evidence for its validity (closeness to truth) and its usefulness (clinical applicability), applying the results in clinical practice and evaluating our performance.


Cerebral Palsy Umbilical Artery Fetal Growth Restriction Perinatal Death Intrauterine Growth Restriction 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. BMJ 1996;312(7023):71–2.PubMedCrossRefGoogle Scholar
  2. Cooke IE, Sackett DL. Evidence based obstetrics and gynaecology. In: Cooke IE, Sackett DL, editors. Evidence-based obstetrics and gynaecology. Bailliere’s Clin Obstet Gynaecol 1996;10:535–49. Google Scholar
  3. 3.
    Cox DN, Wittman BK, Hess M, Ross AG, Lind J, Lindahl S. The psychological impact of diagnostic ultrasound. Obstet Gynecol 1987;70:673–6.PubMedGoogle Scholar
  4. 4.
    Johnson N. Development and potential of fetal pulse oximetry. Contemp Rev Obstet Gynaecol 1992;3:193–200.Google Scholar
  5. 5.
    Thornton JG, Lilford RJ. Do we need randomised trials of antenatal tests of fetal wellbeing? Br J Obstet Gynaecol 1993;100:197–200.PubMedCrossRefGoogle Scholar
  6. 6.
    Manning FA, Platt LD, Sipos L. Antepartum fetal evaluation: development of a fetal biophysical profile. Am J Obstet Gynecol 1980;136:787–95.PubMedGoogle Scholar
  7. Manning FA, Morrison I, Lange IR, Harman CR, Chamberlain PF. Fetal assessment based on fetal biophysical profile scoring: experience in 12,620 referred high–risk pregnancies 1. Perinatal mortality by frequency and etiology. Am J Obstet Gynecol 1985;151:343–50. Google Scholar
  8. 8.
    Tyrell S, Obaid AH, Lilford RJ. Umbilical artery Doppler velocimetry as a predictor of fetal hypoxia and acidosis at birth. Obstet Gynecol 1989;74:332–7.Google Scholar
  9. 9.
    Spence JE, Perciaccante RG, Greig GM, Willard HF, Ledbetter DH, Hejtmancik JF, et al. Uniparental disomy as a mechanism for human disease. Am J Hum Genet 1988;42:217–26.PubMedGoogle Scholar
  10. 10.
    Hall JG. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet 1990;46:857–73.PubMedGoogle Scholar
  11. 11.
    Koistinen HA, Koivisto VA, Andersson S, Karonen SL, Kontula K, Oksanen L, et al. Leptin concentration in cord blood correlates with intrauterine growth. J Clin Endocrinol Metab 1997;82:3328–30.PubMedCrossRefGoogle Scholar
  12. 12.
    Liebel RL. And finally genes for human obesity. Nat Genet 1997;16:218–20.CrossRefGoogle Scholar
  13. 13.
    Johanson R, Lindow SW, van der Eist C, Jaquire Z, van der Westhuizen S, Tucker A. A prospective randomised comparison of the effect of continuous 02 therapy and bedrest on fetuses with absent end–diastolic flow on umbilical artery Doppler waveform analysis. Br J Obstet Gynaecol 1995;102(8):662–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Grimes DA. Randomisation controlled trials: “it ain’t necessarily so”. Obstet Gynecol 1991;78:703–4.PubMedGoogle Scholar
  15. 15.
    Schulz KF, Chalmers I, Grimes DA, et al. Assessing the quality of randomization from reports of controlled trials published in obstetrics and gynecology journals. JAMA 1994;272:125–8.PubMedCrossRefGoogle Scholar
  16. 16.
    McDonough PG. “Leaky randomization”: standard practice–but is it correct? Fertil Steril 1995;64:216–17.Google Scholar
  17. 17.
    Grimes DA, Schulz KF. Methodology citations and the quality of RCTs in obstetrics and gynecology. Am J Obstet Gynecol 1996;174:1312–15.PubMedCrossRefGoogle Scholar
  18. 18.
    CLASP Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994;343: 619–29.CrossRefGoogle Scholar
  19. Nelson KB, Ellenberg JH. Antecedents of cerebral palsy. Multivariate analysis of risk. New Engl J Med 1986;315:81–6. Google Scholar
  20. 20.
    Naeye RL, Peters EC. Antenatal hypoxia and low IQ values. Am J Dis Child 1987;141:50–4.PubMedGoogle Scholar
  21. Sung I-K, Vohr B, Oh W. Growth and neurodevelopmental outcome of very low birth weight infants with intrauterine growth retardation: comparison with control subjects matched by birth weight and gestational age. J Paediatr 1993;123:618–24. Google Scholar
  22. Todd AL, Trudinger BJ, Cole MJ, Cooney GH. Adverse fetal welfare and outcome at 2 years. J Matern Fetal Investl991;l(2):101. Google Scholar
  23. 23.
    Soothill PW, Ajayi RA, Campbell E, Ross EM, Candy JDCA, Snijders RM, et al. Relationship between fetal acidemia at cordocentesis and subsequent neurodevelopment. Ultrasound Obstet Gynaecol 1992;2(2):80–3.CrossRefGoogle Scholar
  24. Gaudier FL, Goldenberg RL, Nelson KG, Peralta-Carcelen M, Johnson SE DuBard MB, et al. Acid base status and subsequent neurosensory impairment in surviving 500 to 1000 gm infants Am J Obstet Gynecol 1994;170:48–53. Google Scholar
  25. 25.
    Goldstein RF, Thompson RJ, Oehler JM, Brazy JE. Influence of acidosis, hypoxemia, and hypotension on neurodevelopmental outcome in very low birth weight infants. Pediatrics 1995;95: 238–43.PubMedGoogle Scholar
  26. 26.
    Hagberg B, Hagberg G, Olow I, Von Wendt L. The changing panorama of cerebral palsy in Sweden. Acta Paediatr Scand 1989;78:283–90.PubMedCrossRefGoogle Scholar
  27. 27.
    Stanley FJ, Watson L. The cerebral palsies in western Australia: trends, 1968–1981. Am J Obstet Gynecol 1988;158:89–93.PubMedGoogle Scholar
  28. 28.
    Pharoah POD, Cooke T, Cooke RWI, Rosenbloom L. Birthweight specific trends in cerebral plasy. Arch Dis Child 1990;65:602–6.PubMedCrossRefGoogle Scholar
  29. Griffiths R. The abilities of young children. A comprehensive system of mental measurement for the first eight years of life. High Wycombe, Bucks: The Test Agency, 1970. Google Scholar
  30. 30.
    GRIT Study Group. When do obstetricians recommend delivery for a high-risk preterm growth-retarded fetus? Eur J Obstet Gynaecol Reprod Biol 1996;67:121–6.CrossRefGoogle Scholar
  31. 31.
    Thornton JG, Lilford RJ. Preterm breech babies, and randomised trials of rare conditions [commentary]. Br J Obstet Gynaecol 1996;103:611–13.PubMedCrossRefGoogle Scholar
  32. 32.
    Lilford RJ, Braunholz D. The statistical basis of public policy: a paradigm shift is overdue. BMJ 1996;313:603–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Freedman L. Bayesian statistical methods. BMJ 1996;313:569–70.Google Scholar
  34. 34.
    Thornton JG, Lilford RJ, Johnson N. Decision analysis in medicine. BMJ 1992;304:1099–103.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2000

Authors and Affiliations

  • James G. Thorton
  • Janet Hornbuckle

There are no affiliations available

Personalised recommendations